| Net Cash Provided by (Used in) Operating Activities |
$34,309,000 |
USD |
-200% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$339,677,000 |
USD |
448% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$1,128,000 |
USD |
-102% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
750,000,000 |
shares |
0% |
Q4 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
489,270,002 |
shares |
14% |
Q4 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$494,004,000 |
USD |
599% |
Q4 2025 |
Q2 2026 |
| Deferred Tax Assets, Valuation Allowance |
$96,976,000 |
USD |
23% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$101,395,000 |
USD |
26% |
Q2 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$1,128,000 |
USD |
-7.5% |
Q3 2025 |
Q1 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$67,973,000 |
USD |
18% |
Q4 2025 |
Q2 2026 |
| Property, Plant and Equipment, Gross |
$81,001,000 |
USD |
7.4% |
Q4 2025 |
Q2 2026 |
| Deferred Income Tax Expense (Benefit) |
$676,000 |
USD |
89% |
Q4 2025 |
Q2 2026 |
| Additional Paid in Capital |
$1,854,064,000 |
USD |
48% |
Q4 2025 |
Q2 2026 |
| Depreciation, Depletion and Amortization |
$1,479,000 |
USD |
147% |
Q3 2025 |
Q1 2026 |
| Interest Expense |
$2,039,000 |
USD |
96% |
Q4 2025 |
Q2 2026 |